<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A topotecan/<z:chebi fb="0" ids="28680">cytarabine</z:chebi> combination has been reported to be effective in patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We report our experience with this regimen in 12 patients with relapsed or secondary <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Extra-hematologic toxicity was low, but the response to the treatment was very poor </plain></SENT>
<SENT sid="3" pm="."><plain>In our opinion, this association is not a treatment option for these patients, but the addition of other agents could improve this results </plain></SENT>
</text></document>